|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| C07K 14/705 | (2006.01) | ||
| G01N 33/74 | (2006.01) | ||
| A61K 31/00 | (2006.01) | ||
| C07K 14/72 | (2006.01) |
| (11) | Patento numeris | 3327144 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17206756.3 |
| Europos patento paraiškos padavimo data | 2014-02-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361768860 P | 2013-02-25 | US | |
| 201361878669 P | 2013-09-17 | US |
| (72) |
COOKE, Vesselina, US
KORN, Joshua, US
KORPAL, Manav, US
ZHOU, Wenlai, US
ZHU, Ping, US
DELACH, Scott, US
CAPONIGRO, Giordano, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | NOVEL ANDROGEN RECEPTOR MUTATION |
| NOVEL ANDROGEN RECEPTOR MUTATION |